Life Sciences Now

Launch of petition against FDA’s ban on 23andMe

Posted on January 23rd, by Michael Shapiro-Barr

In response to the FDA’s warning letter to 23andMe urging that the company halt its direct-to-consumer genetic testing service, a think tank has launched a change.org petition with the goal of urging FDA regulators to back off.  According to the think tank, the petition has reached 10,000 signatures so far.

We recently posted two articles that discuss the different sides of the controversial issue of direct-to-consumer genetic testing.

Read More



Comments are closed.

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Media Quotes

  • Mercedes Meyer, a patent lawyer with the firm Drinker Biddle in Washington, D.C., said the Supreme Court’s failure to provide “bright-line guidance”—a ruling that would settle once-and-for all whether patent settlements are legal or not—means there’s “really no difference now than what was going on.” Mercedes Meyer
    CNBC: High Court Allows FTC to Challenge 'Pay-to-Delay' Generics

From the Blog

President Issues Sanctions to Support Stability in Ukraine

Today, March 6, 2014, President Obama signed a new Executive Order in response to the threats Ukraine is facing to its peace and stability....

New Reprint Guidance Maintains Bipartisan Status Quo

On February 28, 2014, the FDA issued its most recent unofficial guidance on distribution by manufacturers of research concerning off-label uses.  With minor textual revisions,...

High Court Should Reverse 4th Circ.’s Flawed FCA Ruling

The U.S. Supreme Court is currently deciding whether to review the Fourth Circuit’s decision in United States ex rel. Carter v. Halliburton Co., 710...